ArticleFrontiers in oncology2022

PD-1 inhibitors plus nab-paclitaxel-containing chemotherapy for advanced gallbladder cancer in a second-line setting: A retrospective analysis of a case series.

Sirui Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.